Comparative in vitro activities and postantibiotic effects of the oxazolidinone compounds eperezolid (PNU-100592) and linezolid (PNU-100766) versus vancomycin against Staphylococcus aureus, coagulase-negative staphylococci, Enterococcus faecalis, and Enterococcus faecium

Antimicrobial Agents and Chemotherapy

Volumn 42, Issue 3, 1998, Pages 721-724

  Rybak, Michael J ^a,b,c   Cappelletty, Diane M ^a,b,c   Moldovan, Tabitha ^a,b   Aeschlimann, Jeffrey R ^a,b   Kaatz, Glenn W ^a,b,c  

^a DETROIT RECEIVING HOSPITAL   (United States)

^b WAYNE STATE UNIVERSITY   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; EPEREZOLID; LINEZOLID; METICILLIN; OXAZOLIDINONE DERIVATIVE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; CROSS RESISTANCE; DRUG ACTIVITY; DRUG MECHANISM; DRUG POTENCY; ENTEROCOCCUS FAECALIS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; POSTANTIBIOTIC EFFECT; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0031893770     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.42.3.721     Document Type: Article

References (17)

1. Barry, A. L. 1988. In vitro evaluation of DuP 105 and DuP 721, two new oxazolidinone antimicrobial agents. Antimicrob. Agents Chemother. 32:150-152.
2. Brumfitt, W., and J. M. T. Hamilton-Miller. 1992. Antibacterial oxazolidinones. In vitro activity of a new analogue, E3709. Diagn. Microbiol. Infect. Dis. 15:621-624.
3. Craig, W. A., and S. Gudmundsson. 1991. Postantibiotic effect, p. 403-431. In V. Lorian (ed.), Antibiotics in laboratory medicine, 3rd ed. The Williams & Wilkins Co., Baltimore, Md.
4. Daly, J. S., G. M. Eliopolous, E. Reiszner, and R. C. Moellering, Jr. 1988. Mechanism of action and activity of DuP 105 and DuP 721, new oxazolidinone compounds. J. Antimicrob. Chemother. 21:721-730.
5. Daly, J. S., G. M. Eliopolous, S. Willey, and R. C. Moellering, Jr. 1988. Mechanism of action and in vitro and in vivo activities of S-6123, a new oxazolidinone compound. Antimicrob. Agents Chemother. 32:1341-1346.
6. Eustice, D. C., P. A. Felman, I. Zajac, and A. M. Slee. 1988. Mechanism of action of DuP 721: inhibition of an early event during initiation of protein synthesis. Antimicrob. Agents Chemother. 32:1218-1222.
7. Ford, C. W., J. C. Hamel, D. M. Wilson, J. K. Moerman, D. Stapert, R. J. Yancey, Jr., D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antimicrobial agents against experimental bacterial infections. Antimicrob. Agents Chemother. 40:1508-1513.
8. Ford, C. W. Personal communication.
9. Jones, R. N., D. M. Johnson, and M. E. Erwin. 1996. In vitro antimicrobial activities and spectra of U-100592 and U-100766, two novel fluorinated oxazolidinones. Antimicrob. Agents Chemother. 40:720-726.
10. Kaatz, G. W., and S. M. Seo. 1996. In vitro activities of oxazolidinone compounds U100592 and U100766 against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 40:799-801.
11. McGrath, B. J., S. L. Kang, G. W. Kaatz, and M. J. Rybak. 1994. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis. Antimicrob. Agents. Chemother. 38:2034-2040.
12. Mulazimoglu, L., S. D. Drenning, and V. L. Yu. 1996. In vitro activities of two novel oxazolidinones (U100592 and U100766), a new fluoroquinolone (trovafloxacin), and dalfopristin-quinupristin against Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob. Agents Chemother. 40:2428-2430.
13. National Committee for Clinical Laboratory Standards. 1990. Approved standard M7-A2. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 2nd ed. National Committee for Clinical Laboratory Standards, Villanova, Pa.
14. Neu, H. C., A. Novelli, G. Saha, and N.-X. Chin. 1988. In vitro activities of two oxazolidinone antimicrobial agents, DuP 721 and DuP 105. Antimicrob. Agents Chemother. 32:580-583.
15. Pechere, J. C. 1992. In vitro-activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci. J. Antimicrob. Chemother. 30(Suppl. A): 15-18.
16. Slee, A. M., M. A. Wuonola, R. J. McRipley, I. Zajac, M. J. Zawada, P. T. Bartholomew, W. A. Gregory, and M. Forbes. 1987. Oxazolidinones, a new class of synthetic antibacterial agents: in vitro and in vivo activities of DuP 105 and DuP 721. Antimicrob. Agents Chemother. 31:1791-1797.
17. Zurenko, G. E., B. H. Yagi, R. D. Schaadt, J. W. Allison, J. O. Kilburn, S. E. Glickman, D. K. Hutchinson, M. R. Barbachyn, and S. J. Brickner. 1996. In vitro activities of U-100592 and U-100766, novel oxazolidinone antibacterial agents. Antimicrob. Agents Chemother. 40:839-845.